These differences have generated multiple hypotheses on how apoE4 protein may increase AD risk, including Aβ aggregation and clearance, tau hyper-phosphorylation, apoE domain interaction, neuroinflammation, neuroprotection, and differential lipidation states [27,28,29,30,31,32]. The gene discussed is APOE; the disease is Alzheimer disease.